Results 1 to 10 of about 82,627 (193)

Drug repurposing screens reveal cell-type-specific entry pathways and FDA-approved drugs active against SARS-Cov-2

open access: yesCell Reports, 2021
Summary: There is an urgent need for antivirals to treat the newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). To identify new candidates, we screen a repurposing library of ∼3,000 drugs.
Mark Dittmar   +16 more
doaj   +1 more source

Development of a predictive nomogram for switching immunosuppressive drugs in pediatric liver transplant recipients

open access: yesFrontiers in Pediatrics, 2023
BackgroundTacrolimus (TAC) is the preferred calcineurin inhibitor (CNI) for pediatric liver transplant recipients. However, some recipients may not achieve the desired therapeutic window concentration of TAC, leading to poor prognosis.
Guangxiang Gu   +4 more
doaj   +1 more source

Primary livedoid vasculopathy with livedo reticularis: a report of a case successfully treated with cyclosporine and dapsone

open access: yesJournal of the Egyptian Women’s Dermatologic Society, 2021
Livedoid vasculopathies are a group of heterogeneous disorders featuring cutaneous ischemia. Common pathological features include perivascular fibrinoid deposition with absence of evident features of vasculitis.
Galal El Enany   +7 more
doaj   +1 more source

The genome of tolypocladium inflatum: evolution, organization, and expression of the cyclosporin biosynthetic gene cluster. [PDF]

open access: yesPLoS Genetics, 2013
The ascomycete fungus Tolypocladium inflatum, a pathogen of beetle larvae, is best known as the producer of the immunosuppressant drug cyclosporin. The draft genome of T.
Kathryn E Bushley   +12 more
doaj   +1 more source

Severe Vulvar and Perianal Crohn’s Disease: A Case Report and Review of the Literature

open access: yesCase Reports in Dermatology, 2022
Association of vulvar Crohn’s disease (CD) with pyoderma gangrenosum (PG) has been described, yet due to its low prevalence, data on therapeutic management of this association are still limited.
Guillaume Le Cosquer   +8 more
doaj   +1 more source

Pembrolizumab-Induced Toxic Epidermal Necrolysis

open access: yesCase Reports in Oncology, 2022
Immunotherapy has nowadays become part of the mainstay of treatment for several cancers. In this report, we present a case of toxic epidermal necrolysis (TEN) occurring as a relatively rare complication of pembrolizumab, which is a humanized monoclonal ...
Luca Borg   +5 more
doaj   +1 more source

Cyclosporine Nephrotoxicity [PDF]

open access: yesToxicologic Pathology, 1986
Cyclosporine (CSA) is a new immunosuppressant which has selectivity for the immune system and is without systemic side effects at therapeutic doses. In contrast to the cytotoxic class of immunosuppressants, no myelotoxic, teratogenic, mutagenic, or carcinogenic effects were observed.
B, Ryffel, M J, Mihatsch
openaire   +4 more sources

Pitfall in the high-throughput quantification of whole blood cyclosporin A using liquid chromatography-tandem mass spectrometry [PDF]

open access: yes, 2005
In a growing number of laboratories the technique of liquid chromatography-tandem mass spectrometry is used for the quantification of cyclosporin A in whole blood, employing cyclosporin D as the internal standard. Cyclosporin A is extensively metabolized
Spöhrer, Ute, Vogeser, Michael
core   +2 more sources

Rhupus Syndrome Presenting as Interstitial Lung Disease: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2021
Systemic Lupus Erythematosus (SLE) and Rheumatoid Arthritis (RA) are characterised by two distinct immunopathological activities, the T-helper 2 cells play a vital role in pathogenesis of SLE while T-helper 1 cells play an important role in RA.
Vishal Venugopal   +3 more
doaj   +1 more source

A case of rhabdomyolysis after atorvastatin therapy of a liver transplant recipient receiving immunosuppressive therapy with cyclosporine

open access: yesТрансплантология (Москва), 2021
Rationale. To date, liver transplantation is the most effective method of treating end-stage liver failure, and therefore this treatment has become widespread throughout the world.
A. V. Shabunin   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy